Literature DB >> 21320956

Outcome of penetrating keratoplasty for mucopolysaccharidoses.

Erick D Bothun1, Alejandra Decanini, C Gail Summers, Paul J Orchard, Jakub Tolar.   

Abstract

OBJECTIVE: To describe the outcome of penetrating keratoplasty (PK) for corneal opacification in the setting of systemic mucopolysaccharidoses (MPS).
METHODS: A consecutive case series and literature review.
RESULTS: Eight eyes from 5 patients with MPS (MPS I, MPS IV, and MPS VI) and a history of PK met inclusion criteria for our case series at the University of Minnesota Medical Center. The mean age at the time of PK was 40.5 years (range, 11.7-65.3 years). Mean follow-up time after the PK was 4.9 years (range, 1-11 years). Mean (SD) visual acuity before PK was 0.90 (0.38) logMAR. The mean (SD) visual acuity at the last visit for all 8 eyes was 0.32 (0.16) logMAR. Visual acuity improved in 7 of 8 eyes (P = .002). Although early rejection led to repeat PK in 1 eye, no recurrent opacity consistent with MPS was noted in any of the corneal grafts. In a literature review, we found 23 reports documenting 40 initial and 3 repeat cases of PK in the setting of MPS. Of these, 31 initial and 2 repeat corneal grafts were reportedly clear during follow-up, ranging from 0.25 to 13 years.
CONCLUSIONS: Penetrating keratoplasty is often a beneficial intervention in appropriate patients with corneal clouding due to MPS. Improvement in vision can be obtained with stable, clear corneal grafts in this population.

Entities:  

Mesh:

Year:  2011        PMID: 21320956     DOI: 10.1001/archophthalmol.2010.341

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

Review 1.  Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses.

Authors:  Carlton R Fenzl; Kyla Teramoto; Majid Moshirfar
Journal:  Clin Ophthalmol       Date:  2015-09-07

2.  Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance.

Authors:  Mehmet Umut Akyol; Tord D Alden; Hernan Amartino; Jane Ashworth; Kumar Belani; Kenneth I Berger; Andrea Borgo; Elizabeth Braunlin; Yoshikatsu Eto; Jeffrey I Gold; Andrea Jester; Simon A Jones; Cengiz Karsli; William Mackenzie; Diane Ruschel Marinho; Andrew McFadyen; Jim McGill; John J Mitchell; Joseph Muenzer; Torayuki Okuyama; Paul J Orchard; Bob Stevens; Sophie Thomas; Robert Walker; Robert Wynn; Roberto Giugliani; Paul Harmatz; Christian Hendriksz; Maurizio Scarpa
Journal:  Orphanet J Rare Dis       Date:  2019-06-13       Impact factor: 4.123

Review 3.  Mucopolysaccharidosis: A broad review.

Authors:  Ritu Nagpal; Ram Bharos Goyal; K Priyadarshini; Seema Kashyap; Mohita Sharma; Rajesh Sinha; Namrata Sharma
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

4.  Ocular Tolerability and Immune Response to Corneal Intrastromal AAV-IDUA Gene Therapy in New Zealand White Rabbits.

Authors:  Liujiang Song; Jacquelyn J Bower; Telmo Llanga; Jacklyn H Salmon; Matthew L Hirsch; Brian C Gilger
Journal:  Mol Ther Methods Clin Dev       Date:  2020-05-22       Impact factor: 6.698

5.  Multimodal imaging of Hurler syndrome-related keratopathy treated with deep anterior lamellar keratoplasty.

Authors:  Elodie Da Cunha; Cristina Georgeon; Nacim Bouheraoua; Marc Putterman; Françoise Brignole-Baudouin; Vincent M Borderie
Journal:  BMC Ophthalmol       Date:  2020-10-31       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.